GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (NSE:BIOCON) » Definitions » Other Long-Term Liabilities

Biocon (NSE:BIOCON) Other Long-Term Liabilities : ₹20,123 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Biocon Other Long-Term Liabilities?

Biocon's other long-term liabilities for the quarter that ended in Mar. 2024 was ₹20,123 Mil.

Biocon's quarterly other long-term liabilities declined from Sep. 2023 (₹45,669 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹20,123 Mil).

Biocon's annual other long-term liabilities increased from Mar. 2022 (₹28,760 Mil) to Mar. 2023 (₹55,437 Mil) but then declined from Mar. 2023 (₹55,437 Mil) to Mar. 2024 (₹20,123 Mil).

Biocon Other Long-Term Liabilities Historical Data

The historical data trend for Biocon's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon Other Long-Term Liabilities Chart

Biocon Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biocon Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biocon Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Biocon Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Biocon's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocon (NSE:BIOCON) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (NSE:BIOCON) » Definitions » Other Long-Term Liabilities
Comparable Companies
BOM:539268 BOM:543960 BOM:540701 BOM:543434 NSE:ZOTA BOM:531349 NSE:BALAXI BOM:500259 BOM:524717 BOM:532890 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 HKSE:02269 MRNA XBRU:ARGX BNTX
Traded in Other Exchanges
532523:India
Address
20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560 100
Website
https://www.biocon.com
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.

Biocon (NSE:BIOCON) Headlines

No Headlines